Thomas P. Monath
Corporate Officer/Principal bij VAXXINITY, INC.
Profiel
Thomas P.
Monath is currently the Director at Sentinext Therapeutics Sdn.
Bhd.
and US Biologic, Inc. He is also the Chief Operating & Scientific Officer at BioProtection Systems Corp., the Chief Scientific Officer & Managing Partner at Crozet BioPharma LLC, and the Chief Development Officer at Vaxxinity, Inc. Previously, Dr. Monath held positions as the Director at Novavax, Inc., the Executive Director & Chief Scientific Officer at Acambis Plc, and the Director at Sanaria, Inc. He also served as the Director at Xcellerex, Inc., Rapid Micro Biosystems, Inc., Juvaris BioTherapeutics, Inc., VaxInnate Corp., and Hookipa Biotech AG.
Additionally, he was the Chief Scientific Officer at NewLink Genetics Corp.
and the Chief-Virology Division at the U.S.
Army Medical Research Institute for Infectious Diseases.
Dr. Monath's career also includes being the Director-Vector Borne Viral Diseases Division at the Centers for Disease Control & Prevention and the National Centers for Disease Control.
He was a Partner at Kleiner Perkins Caufield & Byers LLC and served as the President of the American Society of Tropical Medicine & Hygiene.
He also held the position of Chief Medical Officer at HX Diagnostics, Inc.Dr. Monath received a doctorate degree from Harvard Medical School and an undergraduate degree from Harvard College.
Actieve functies van Thomas P. Monath
| Bedrijven | Functie | Begin |
|---|---|---|
| VAXXINITY, INC. | Corporate Officer/Principal | - |
BioProtection Systems Corp.
 BioProtection Systems Corp. BiotechnologyHealth Technology Part of Lumos Pharma, Inc., BioProtection Systems Corp. is a private company that manufactures biological products. The company is based in Ames, IA. | Chief Operating Officer | 15-11-2014 |
Crozet BioPharma LLC
 Crozet BioPharma LLC BiotechnologyHealth Technology Crozet BioPharma LLC is a private company based in Devens, MA that focuses on accelerating the development of biological products to prevent or treat important human diseases. The company's founding principle is to have a lasting, positive impact on people's health and lives, and they take pride in putting their knowledge and expertise to work for this cause every day. | Chief Tech/Sci/R&D Officer | - |
US Biologic, Inc.
 US Biologic, Inc. BiotechnologyHealth Technology US Biologic, Inc. develops and commercializes vaccines, anti-microbial and preventative therapeutics. Its solutions include tick-borne diseases, pet health, food-animal health, and predictive analytics. The company is headquartered in Memphis, TN. | Director/Board Member | - |
Sentinext Therapeutics Sdn. Bhd.
 Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Director/Board Member | - |
Eerdere bekende functies van Thomas P. Monath
| Bedrijven | Functie | Einde |
|---|---|---|
| NOVAVAX, INC. | Director/Board Member | 02-11-2009 |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Chief Tech/Sci/R&D Officer | 01-01-2006 |
Sanaria, Inc.
 Sanaria, Inc. BiotechnologyHealth Technology Sanaria, Inc. operates as biotechnology company. The firm develops vaccine protective against malaria caused by the pathogen Plasmodium falciparum. Its products include Plasmodium falciparum Sporozoite Reagents, PfSPZ Challenge Mosquitoes, Plasmodium Reagents, Plasmodium Reagent Slides, Anopheles Reagents and Plasmodium Assay Services. The company is headquartered in Rockville, MD. | Director/Board Member | 01-01-2006 |
| U.S. Army Medical Research Institute for Infectious Diseases | Corporate Officer/Principal | 01-01-1992 |
| ░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Thomas P. Monath
| Harvard Medical School | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| RAPID MICRO BIOSYSTEMS, INC. | Producer Manufacturing |
| VAXXINITY, INC. | Health Technology |
| Bedrijven in privébezit | 16 |
|---|---|
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
Sanaria, Inc.
Sanaria, Inc. BiotechnologyHealth Technology Sanaria, Inc. operates as biotechnology company. The firm develops vaccine protective against malaria caused by the pathogen Plasmodium falciparum. Its products include Plasmodium falciparum Sporozoite Reagents, PfSPZ Challenge Mosquitoes, Plasmodium Reagents, Plasmodium Reagent Slides, Anopheles Reagents and Plasmodium Assay Services. The company is headquartered in Rockville, MD. | Health Technology |
Xcellerex, Inc.
 Xcellerex, Inc. Pharmaceuticals: MajorHealth Technology Xcellerex, Inc. manufactures and provides equipment to produce bio-molecules. Its products and services include FlexFactory, a bioprocess manufacturing platform that handles the production of bio-products, such as vaccines, yeast and insulins. The company was founded by Parrish M. Galliher in 2002 and was headquartered in Marlborough, MA. | Health Technology |
BioProtection Systems Corp.
BioProtection Systems Corp. BiotechnologyHealth Technology Part of Lumos Pharma, Inc., BioProtection Systems Corp. is a private company that manufactures biological products. The company is based in Ames, IA. | Health Technology |
Kleiner Perkins Caufield & Byers LLC
 Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers LLC (Kleiner Perkins Caufield & Byers) is a venture capital firm founded in 1972 by Eugene Kleiner, Thomas Perkins, Brook Byers and Frank J. Caufield. The firm is headquartered in California, US. | Finance |
Centers for Disease Control & Prevention
 Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | Government |
Juvaris BioTherapeutics, Inc.
 Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Health Technology |
American Society of Tropical Medicine & Hygiene
 American Society of Tropical Medicine & Hygiene Miscellaneous Commercial ServicesCommercial Services The American Society of Tropical Medicine & Hygiene is a health community dedicated to reducing the worldwide burden of tropical infectious diseases and improving health. The non-profit company is based in Northbrook, IL. Members have access to research on the latest diseases and treatments, a standing within their community, learning about clinical cases and field work, and finding collaborators. | Commercial Services |
HX Diagnostics, Inc.
 HX Diagnostics, Inc. Medical/Nursing ServicesHealth Services HX Diagnostics, Inc. provides diagnostic services for infectious diseases. It develops and commercializes seasonal and pandemic influenza assays that allow clinicians to make assessments of their patient's health status. The company was founded in 2006 and is headquartered in San Diego, CA. | Health Services |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Health Technology |
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Health Technology |
US Biologic, Inc.
US Biologic, Inc. BiotechnologyHealth Technology US Biologic, Inc. develops and commercializes vaccines, anti-microbial and preventative therapeutics. Its solutions include tick-borne diseases, pet health, food-animal health, and predictive analytics. The company is headquartered in Memphis, TN. | Health Technology |
Crozet BioPharma LLC
Crozet BioPharma LLC BiotechnologyHealth Technology Crozet BioPharma LLC is a private company based in Devens, MA that focuses on accelerating the development of biological products to prevent or treat important human diseases. The company's founding principle is to have a lasting, positive impact on people's health and lives, and they take pride in putting their knowledge and expertise to work for this cause every day. | Health Technology |
| National Centers for Disease Control |
